Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5-6 years after completion of the primary series

The tetravalent dengue vaccine (CYD-TDV; Dengvaxia®) is administered on a three-dose schedule, 6 months apart in those aged ≥9 years in a number of dengue-endemic countries in Asia and Latin America. In this study, CYD63 (NCT02824198), participants aged 9-45 years at first vaccination, and who had r...

詳細記述

保存先:
書誌詳細
主要な著者: Juliana Park (著者), Sophia Archuleta (著者), May-Lin Helen Oh (著者), Lynette Pei-Chi Shek (著者), Jing Jin (著者), Matthew Bonaparte (著者), Carina Frago (著者), Alain Bouckenooghe (著者)
フォーマット: 図書
出版事項: Taylor & Francis Group, 2020-03-01T00:00:00Z.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

インターネット

Connect to this object online.

3rd Floor Main Library

予約・返却請求 3rd Floor Main Library
請求記号: A1234.567
所蔵 1 利用可